Lumira Ventures

Portfolio Co Investors 2026 for Lumira Ventures: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Lumira Ventures accounts for 19 tracked companies with verified cap-table data, 19 of which disclose round sizes totalling $4.5B. The median disclosed raise is $127M, and the largest is HistoSonics at $2.3B, ahead of Bardy Diagnostics ($375M) and Cardiac Dimensions ($200M).

The names that recur most often on these co-invested cap tables are Lumira Ventures (19 companies), Hatteras Venture Partners (2 companies), SV Health Investors (2 companies), Sofinnova Investments (2 companies), Alexandria Venture Investments (2 companies), OrbiMed (2 companies). By latest disclosed round, the market skews Series B (7), Series A (5), Growth (2), IPO (1).

Best funded Lumira Ventures companies

  1. HistoSonics — $2.3B (latest: IPO)
  2. Bardy Diagnostics — $375M (latest: Series B)
  3. Cardiac Dimensions — $200M (latest: Series E)
  4. Corvia Medical — $163M (latest: Series U)
  5. Axonis Therapeutics — $157M (latest: Series A)
  6. Congruence Therapeutics — $140M (latest: Series B)
  7. Endogenex — $138M (latest: Series C)
  8. enGene — $135M (latest: Growth)
  9. Cour Pharmaceuticals Development — $135M (latest: Series A)
  10. BioTheryX — $127M
  11. XyloCor Therapeutics — $108M (latest: Series B)
  12. Notch Therapeutics — $85M (latest: Series A)
  13. OncoMyx Therapeutics — $75M (latest: Series B)
  14. Think Research — $71M (latest: Growth)
  15. Puzzle Medical Devices — $64M (latest: Series A)

Lumira Ventures — related firms and companies (56)

Lumira Ventures alternatives · All research reports